UGT1A1 and metabolic dysfunction-associated steatotic liver disease: Nevertheless, in one study from Taiwan, the protective effects of serum bilirubin concentrations and UGT1A1 variants were described in pediatric patients with NAFLD with an independent negative association between variant UGT1A1*6 genotypes (prevalent in Asian populations) and NAFLD prevalence [16].